| Biophysical properties of the clinical-stage antibody landscape T Jain, T Sun, S Durand, A Hall, NR Houston, JH Nett, B Sharkey, ... Proceedings of the National Academy of Sciences 114 (5), 944-949, 2017 | 495 | 2017 |
| High-throughput screening for developability during early-stage antibody discovery using self-interaction nanoparticle spectroscopy Y Liu, I Caffry, J Wu, SB Geng, T Jain, T Sun, F Reid, Y Cao, P Estep, Y Yu, ... MAbs 6 (2), 483-492, 2014 | 156 | 2014 |
| Predicting Antibody Developability Profiles Through Early Stage Discovery Screening M Bailly, C Mieczkowski, V Juan, E Metwally, D Tomazela, J Baker, ... Mabs 12 (1), 1743053, 2020 | 149 | 2020 |
| High throughput cross-interaction measures for human IgG1 antibodies correlate with clearance rates in mice RL Kelly, T Sun, T Jain, I Caffry, Y Yu, Y Cao, H Lynaugh, M Brown, ... MAbs 7 (4), 770-777, 2015 | 98 | 2015 |
| PEO-based star copolymers as stabilizers for water-in-oil or oil-in-water emulsions W Li, Y Yu, M Lamson, MS Silverstein, RD Tilton, K Matyjaszewski Macromolecules 45 (23), 9419-9426, 2012 | 92 | 2012 |
| An alternative assay to hydrophobic interaction chromatography for high-throughput characterization of monoclonal antibodies P Estep, I Caffry, Y Yu, T Sun, Y Cao, H Lynaugh, T Jain, M Vásquez, ... MAbs 7 (3), 553-561, 2015 | 58 | 2015 |
| Target-independent variable region mediated effects on antibody clearance can be FcRn independent RL Kelly, Y Yu, T Sun, I Caffry, H Lynaugh, M Brown, T Jain, Y Xu, ... MAbs 8 (7), 1269-1275, 2016 | 36 | 2016 |
| Broad epitope coverage of a human in vitro antibody library A Sivasubramanian, P Estep, H Lynaugh, Y Yu, A Miles, J Eckman, ... MAbs 9 (1), 29-42, 2017 | 20 | 2017 |
| Understanding ForteBio’s Sensors for High-Throughput Kinetic and Epitope Screening for Purified Antibodies and Yeast Culture Supernatant Y Yu, S Mitchell, H Lynaugh, M Brown, RP Nobrega, X Zhi, T Sun, I Caffry, ... Journal of biomolecular screening 21 (1), 88-95, 2016 | 20 | 2016 |
| Cytosolic delivery of siRNA by ultra-high affinity dsRNA binding proteins NJ Yang, MJ Kauke, F Sun, LF Yang, KF Maass, MW Traxlmayr, Y Yu, ... Nucleic acids research 45 (13), 7602-7614, 2017 | 17 | 2017 |
| Differences in human IgG1 and IgG4 S228P monoclonal antibodies viscosity and self-interactions: Experimental assessment and computational predictions of domain interactions PK Lai, G Ghag, Y Yu, V Juan, L Fayadat-Dilman, BL Trout Mabs 13 (1), 1991256, 2021 | 12 | 2021 |
| Picomolar solution phase affinity measurement by BLI-ELISA, Fortebio Interact Y Liu, P Estep, F Reid, Y Cao, T Sun, Y Yu, I Caffry, Y Xu Winter 7, 7-9, 2014 | 5* | 2014 |
| Crystal Structure and Characterization of Human Heavy-Chain Only Antibodies Reveals a Novel, Stable Dimeric Structure Similar to Monoclonal Antibodies C Mieczkowski, S Bahmanjah, Y Yu, J Baker, G Raghunathan, ... Antibodies 9 (4), 66, 2020 | 4 | 2020 |
| Database-Centric Method for Automated High-Throughput Deconvolution and Analysis of Kinetic Antibody Screening Data RP Nobrega, M Brown, C Williams, C Sumner, P Estep, I Caffry, Y Yu, ... SLAS TECHNOLOGY: Translating Life Sciences Innovation 22 (5), 547-556, 2017 | | 2017 |
Tushar JainAdimabVerified email at adimab.com
